Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
The psychosocial difficulties in brain disorders that explain short term changes in health outcomes.
Multidisciplinary management of multiple sclerosis symptoms.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Gilenya Safety Update
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
Monoclonal Antibodies in Treatment of Multiple Sclerosis.
Sex-specific control of CNS autoimmunity by p38 MAPK signaling in myeloid cells.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Is There Extra Cost of Institutional Care for MS Patients?
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.
[Neuropathology of multiple sclerosis].
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
Estimating time-varying effects for overdispersed recurrent events data with treatment switching.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Pages
« first
‹ previous
…
365
366
367
368
369
370
371
372
373
…
next ›
last »